Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Female hair loss is influenced by genetics and hormones, often starting in middle age or after hormonal changes.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

Aromatase inhibitors cause male pattern hair loss in women.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

The new drug delivery system improves exemestane's absorption and effectiveness.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Juniperus plants contain compounds with potential for developing various medical treatments.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.